Matabat, Baby Girl .

HRN: 29-38-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/26/2026
08/02/2026
IV
42MG
Q24H
T/C NEONATAL SEPSIS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: